Search

Search Funnelback University

Search powered by Funnelback
10 results 20 results 50 results
Relevance Date (Newest first) Date (Oldest first) Title (A-Z) Title (Z-A) Distance URL (A-Z) URL (Z-A) Shuffle
81 - 100 of 218 search results for `Research news` |u:www-neurosciences.medschl.cam.ac.uk

  1. Fully-matching results

  2. Featured news Archives - Page 3 of 5 - Department of Clinical…

    https://www-neurosciences.medschl.cam.ac.uk/blog/category/featured-news/page/3/
    23 Feb 2024: Filed Under:10th August 2021. Dr Timothy Rittman is the clinical lead of the QMIN-MC trial, which uses a machine learning algorithm developed by Prof Zoe Kourtzi, research lead at ... The new Fellows have been selected for their exceptional contributions

  3. Previous staff members

    https://www-neurosciences.medschl.cam.ac.uk/mitocamb/meet-our-staff/previous-staff-members/
    23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. Previous staff members. Click photos below to find out more about our previous staff.

  4. Featured news Archives - Page 4 of 5 - Department of Clinical…

    https://www-neurosciences.medschl.cam.ac.uk/blog/category/featured-news/page/4/
    23 Feb 2024: Jess’ research has led to the launch of a clinical trial, which is testing a new treatment to slow down the […]. Filed Under:5th June 2019. Results indicate that early treatment ... MRC Clinical Director He joins the senior management team and will

  5. Jelle van den Ameele

    https://www-neurosciences.medschl.cam.ac.uk/mitocamb/meet-our-staff/jelle-van-den-ameele/
    23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. Jelle van den Ameele. Jelle van den Ameele. ... In 2020, Jelle became a Wellcome Clinical Research Career Development Fellow at the Department of Clinical Neurosciences and MRC Mitochondrial Biology Unit

  6. Marina Salorio-Corbetto

    https://www-neurosciences.medschl.cam.ac.uk/sound-lab/sound-team/marina-salorio-corbetto/
    23 Feb 2024: SOUND Laboratory. Marina Salorio-Corbetto. Marina is a Research Associate who has previously worked as a clinical audiologist. ... While at the Auditory Perception Group, Marina started collaborating with Dr Josephine Marriage as a Research Audiologist.

  7. Publications - Cambridge Clinical Multiple Sclerosis Research

    https://www-neurosciences.medschl.cam.ac.uk/cambridge-clinical-ms-research/publications/
    23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. Publications. Six months of bexarotene reduces the VEP latency, implying remyelination (Brown Lancet Neurol 2021). ... PMID: 36116011; PMCID: PMC9539389. Needham EJ, …. Coles AJ, Menon DK; Cambridge

  8. CCMR2 Trial Starts - Cambridge Clinical Multiple Sclerosis Research

    https://www-neurosciences.medschl.cam.ac.uk/cambridge-clinical-ms-research/ccmr2-trial-starts/
    23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. CCMR2 Trial Starts. 22nd March 2022. ... purpose of this research is therefore to assess whether metformin and clemastine.

  9. News Archives - Cambridge Clinical Multiple Sclerosis Research

    https://www-neurosciences.medschl.cam.ac.uk/cambridge-clinical-ms-research/category/featured-news/
    23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. ... This new research is a major milestone in our plan to stop MS and we’re incredibly excited about the potential it’s shown for future studies.

  10. Psychosis Clinical Trial - Cambridge Clinical Multiple Sclerosis…

    https://www-neurosciences.medschl.cam.ac.uk/cambridge-clinical-ms-research/psychosis-clinical-trial/
    23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. Psychosis Clinical Trial. SINAPPS-2 trial. SINAPPS2 is a phase II ongoing clinical trial aiming to test the efficacy and safety of immunotherapy (intravenous immunoglobulin combined

  11. Children with MS - Cambridge Clinical Multiple Sclerosis Research

    https://www-neurosciences.medschl.cam.ac.uk/cambridge-clinical-ms-research/children-with-ms/
    23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. Children with MS. We are exploring changes in myelin and nerve health over time in children with demyelinating diseases, such as multiple sclerosis (MS).

  12. Anaphylaxis to alemtuzumab - Cambridge Clinical Multiple Sclerosis…

    https://www-neurosciences.medschl.cam.ac.uk/cambridge-clinical-ms-research/anaphylaxis-to-alemtuzumab/
    23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. Anaphylaxis to alemtuzumab. 20th February 2019. ... PubMed PMID: 30715557. Filed Under: News.

  13. Greg Winter Nobel Prize - Cambridge Clinical Multiple Sclerosis…

    https://www-neurosciences.medschl.cam.ac.uk/cambridge-clinical-ms-research/greg-winter-nobel-prize/
    23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. Greg Winter Nobel Prize. 3rd October 2018. ... Wonderful news! Greg Winter today won the Nobel Prize for Chemistry (Shared with George Smith adn Frances Arnold).

  14. Bexarotene trial published! - Cambridge Clinical Multiple Sclerosis…

    https://www-neurosciences.medschl.cam.ac.uk/cambridge-clinical-ms-research/bexarotene-trial-published/
    23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. Bexarotene trial published! 19th August 2021. ... It is a mixture of good and bad news! Sadly, we concluded that the drug has too many side-effects to take further as a treatment for people with MS.

  15. Personalised Treatments (Theme Lead: Will Brown) - Cambridge Clinical …

    https://www-neurosciences.medschl.cam.ac.uk/cambridge-clinical-ms-research/personalised-treatments/
    23 Feb 2024: We enable everyone in the UK to participate in the most crucial research, and we reduce healthcare inequalities. ... To consent to approved research being done at their hospital using their existing information.

  16. Alemtuzumab Trial Results - Cambridge Clinical Multiple Sclerosis…

    https://www-neurosciences.medschl.cam.ac.uk/cambridge-clinical-ms-research/alemtuzumab-trial-results/
    23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. Alemtuzumab Trial Results. These are the “headline results” from the three sponsored clinical trial results.

  17. Alemtuzumab (Lemtrada) - Cambridge Clinical Multiple Sclerosis…

    https://www-neurosciences.medschl.cam.ac.uk/cambridge-clinical-ms-research/alemtuzumab-lemtrada/
    23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. Alemtuzumab (Lemtrada). The history of alemtuzumab use in multiple sclerosis.

  18. Survey Studies

    https://www-neurosciences.medschl.cam.ac.uk/mitocamb/our-research-2/research-studies/survey-studies/
    23 Feb 2024: Cambridge Clinical Mitochondrial Research Group. Survey Studies. Please see below for further details on our studies that are designed to assess patient experience.

  19. Clinical Neurology Training - Department of Clinical Neurosciences

    https://www-neurosciences.medschl.cam.ac.uk/workandstudy/postgraduate-training/clinical-neurology-training/
    23 Feb 2024: Our aim is to train excellent neurologists, with subspeciality expertise, and advanced training in research, education or management. ... We aspire to be flexible, responsive and ambitious. For those interested in neuroscience research, all of the

  20. Neuroinflammation & MS - Department of Clinical Neurosciences

    https://www-neurosciences.medschl.cam.ac.uk/research/immune-dysfunction-in-the-nervous-system/
    23 Feb 2024: For more details see our website for Clinical MS Research.

  21. NHS England algorithm published - Cambridge Clinical Multiple…

    https://www-neurosciences.medschl.cam.ac.uk/cambridge-clinical-ms-research/nhs-england-algorithm-published/
    23 Feb 2024: Cambridge Clinical Multiple Sclerosis Research. News. NHS England algorithm published. 16th September 2018.

Refine your results

Date

Search history

Recently clicked results

Recently clicked results

Your click history is empty.

Recent searches

Recent searches

Your search history is empty.